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Introduction
Diabetes mellitus is a major health and social problem.
The prevalence of diabetes for all age groups worldwide was
estimated to be 2.8% in 2000 and 4.4% in 2030 
1. Type 2
diabetes mellitus (DMT2) (adult-onset diabetes) is the most
common form of this disease, which is present in 90–95% of
patients 
2. In Serbia, the prevalence of DMT2 in the year
2000 was 4.5%, both in men and women 
3. Diabetes has
negative impact on physical, psychological and social func-
tioning 
4. DMT2 is a disease related to stress and stressful
life events which may have an important role in its patho-
genesis, course and outcome.
The interactions between behaviour, central nervous
and endocrine systems that might cause immunosuppression
is the most fascinating finding in modern medicine, and its
implications are important for the prevention and treatment
of somatic illnesses 
5.
  The patophysiological mechanisms
related to the role of stressful life events on the emergence of
DMT2 include hypothalamic arousal syndrome, with parallel
activation of the hypothalamic-pituitary-adrenal axis (HPA)
and the central sympathetic nervous system, leading to de-
velopment of endocrine abnormalities, insulin resistance, and
DMT2 
6.
DMT2 is a chronic, self-managed disease that signifi-
cantly affects the lives of patients and their families. Ac-
cording to the biopsychosocial model originally proposed by
Engel 
7, the mind and body are two important systems that
are interconnected. The model offers additional insights into
how chronic illnesses such as diabetes can affect daily life.
This model makes a distinction between pathological proc-
esses that cause disease, which includes the individual’s per-
ception of his or her health and its subsequent impact on
health. Stress and coping with diabetes can affect the severity
of disease directly, through pathophysiological processes or
indirectly, through patients’ own perception of illness by
deteriorating adherence to therapy and daily functioning.
The results of numerous studies indicated the presence
of difficulties of many patients with diabetes living with their
disease 
8–10, such as the threat of serious complications (renal
disease, amputation, blindness) and the potential for reduced
life expectancy 
11. The constant stress of maintaining tight
glycemic control can result in two types of psychological
distress: subclinical emotional distress and diagnosable psy-
chological disorders 
10.
Comorbid mental disorders in patients with type
2 diabetes
According to the results of a number of studies, anxious
disorders and depression are the most frequent psychiatric
comorbid conditions in DMT2 patients 
12, 13. People with
diabetes of any type have a 20% higher prevalence of life-
time diagnosis of anxiety than those without it 
14. General-
ized anxiety disorder (GAD) appears to be the most common
anxiety disorder in this patients' population, with prevalence
rate ranging from 13% to 14% 
15. Panic disorder (PD), post-
traumatic stress disorder (PTSD) and social phobia are also
more frequent in patients with DMT2 than in general popu-
lation.
Depression occurs two to three times more frequently in
DMT2 patients in relation to the general population 
16. De-
pression is also more common in patients with undiag-
nosed 
17 and newly diagnosed DMT2 
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between DMT2 and depression appears to be bidirectional in
terms of causes, influences and treatment outcomes 
19.
Comorbidity of these two conditions is associated with sub-
optimal adherence to pharmacological therapy and dietary
regimen, resulting in unfavorable clinical outcome 
20, 21. An-
tidepressant treatment of comorbid depression in DMT2 pa-
tients is associated with reduction of depressive symptoms
and improvement of quality of life. However, results refer-
ring to the effect of antidepressant treatment on improvement
of glycemic control are inconsistent 
22–24.
Diabetes is clearly associated with impaired health-
related quality of life, in comparison with the population
without diabetes, independently of psychological factors and
presence of somatic comorbid diseases 
25, which was shown
in many studies 
13,  26– 28. In one of our studies, the severity of
self-rated depressive symptoms in patients with DMT2 sig-
nificantly inversely correlated with both social adjustment
and quality of life 
29.
Along with anxious disorders and depression, various
other psychiatric disorders are present among DMT2 pa-
tients: adjustment disorder 
30, substance and/or alcohol use
disorders 
31, 32, bipolar I disorder 
33 and schizophrenia 
34.
DMT2 also increases the risk of developing dementia,
mostly Alzheimer's disease and vascular dementia 
35.
Diabetes-related distress
Diabetes-related distress (DD), a measure of health-
related quality of life, includes negative emotional reactions
to the diagnosis, threat of complications, self-management
demands (testing and monitoring blood glucose level, com-
pliance with dietary regimen and engaging in regular physi-
cal activity), treatment and social support. The results of a
large cross-national DAWN study (The Diabetes Attitudes,
Wishes, and Needs Study), examining the experiences of pa-
tients and health professionals in dealing with diabetes, have
shown that DD was frequently present and interfered with
their self-management efforts 
36, 37. The majority of patients
(85.2%) reported feelings of shock, guilt, anger, anxiety, de-
pression and helplessness at the time of diagnosis. The dis-
tress remained common in the long period of time after diag-
nosis (15 years in average) 
36. Of particular clinical impor-
tance are adaptation problems associated with repeated hy-
poglycaemic episodes and the implementation of insulin
therapy.
Although emotional problems related to diabetes in
majority of patients are not severe enough to fulfil criteria for
mental disorders, they are associated with worsening of
quality of life and self-management of disease 
38. DD may
differ by country and ethnicity due to cultural influences and
health care system factors.
Clinical, behavioural and biological correlates of
diabetes–related distress
DD was found to be an important contributor both to
poor metabolic control and suboptimal adherence to treat-
ment. One of important barrier to optimal adherence in
DMT2 patients is the presence of multiple somatic comorbid
illnesses, each having its own set of guidelines. That could
further complicate adherence to treatment and self-
management of the disease 
39, 40.
Several cross-sectional studies have shown that DD is
associated with glycemic control 
41–45, obesity, depressive
symptoms, and quality of life 
43. The psychosocial factors di-
rectly influenced diabetes self-care habits 
42 and women re-
ported significantly higher DD 
44. According to the results of
prospective studies, DD predicted glycemic control 
46, 47, in-
directly through self-efficacy 
47. Reduction of the intensity of
DD, not a change in depressive symptoms, was associated
with improvement of glycemic control 
48–50. A diabetes self-
management education intervention has proven successful in
patients of different ethnic origin 
49. Fisher et al. 
51 have
shown that DD was significantly associated with glycemic
control and physical activity and that both DD and severity
of depression were significantly and independently associ-
ated with diet and adherence to medication.
There are several studies that clearly showed an asso-
ciation between DD and type of antidiabetic therapy. The
patients treated with insulin experienced higher DD in com-
parison with those who were treated with oral hypoglicemic
therapy or diet 
52. A negative appraisal of insulin therapy was
significantly associated with higher level of DD, higher se-
verity of depression and low education 
53, 54.
Hypoglycemia is often associated with unpleasant
symptoms, such as tremors, profuse sweating, cognitive dys-
function, and irritability. Risk factors for the emergence of
hypoglycemia would be the following: a history of hypogly-
cemia length of time since the first insulin treatment and a
higher level of variability in blood glucose level. Severe hy-
poglicemic reactions can lead to unconsciousness, coma and
death. Patients may manifest subclinical symptoms of anxi-
ety related to hypoglycemia that may also adversely affect
diabetes self-management. A fear of hypoglicemia is linked
to both state and trait anxiety, although this relationship is
complex 
55.
“Psychological insulin resistance” (PIR) (patients' re-
luctance to both initiate and intensify insulin therapy) repre-
sents a complex of beliefs about the meaning of insulin ther-
apy, poor self-efficacy concerning the skills needed for this,
a lack of accurate information, the fear of unwanted effects
and complications from insulin use, as well as lifestyle ad-
aptations, restrictions required by insulin use and social
stigma 
56, 57. Worry about efficacy was the factor most
strongly correlated with delay of insulin therapy 
54, and self-
blame has been identified as the attitude most predictive of
patients' unwillingness to begin insulin therapy 
58. PIR is the
most frequent among females and ethnic minorities 
59. Ap-
proximately 9% of diabetic patients on insulin treatment re-
ported anxiety symptoms related to self-injecting 
60.
Psychological factors and psychiatric disorders
associated with diabetes–related distress
The results of 18-months study showed that risk factors
for subsequent DD over time were female gender, previouslyStrana 1140 VOJNOSANITETSKI PREGLED Volumen 70, Broj 12
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having major depression, experiencing more negative events
or more chronic stress, having more complications, poor diet
and low exercise. Negative life events increased the negative
effects of both poor glycemic control and complications on
the emergence of distress over time 
61.
Personal characteristics of patients with DMT2, such as
coping style and temperament could also significantly impact
the intensity of DD. Poor coping with anger may cause
poorer glycemic control by provoking greater DD 
62. A clear
majority of patients with diabetes of different nationalities
and cultural characteristics reported to accept their dis-
ease 
63, 64. Denial and/or mental disengagement and resigna-
tion were present only in a small minority of patients. In a
Norwegian survey 40% of the respondents reported that they
often blamed themselves. Self-blame correlated significantly
with both active and passive coping styles 
63. The most fre-
quently used coping strategies in Turkish patients were ac-
ceptance, religion, planning, positive reframing, instrumental
support, emotional support, self-distraction and venting. The
effect of certain coping strategies on patient's level of anxiety
may be indicative of cultural differences in how patients
from various cultures distract or vent their DD 
64. A recent
study 
65 showed a greater variance in emotional distress ac-
counted for by coping styles, and perceived support than by
clinical factors.
There are few studies of temperament and metabolic
control in patients with DMT2. Patients with excessive de-
pressive and anxious temperaments had worse psychological
adjustment to diabetes, more depressive symptoms and
worse metabolic control. Only depressive temperament was
independently associated with metabolic control 
66. These
findings may indicate that healthcare providers should pay
more attention to non-clinical factors such as personality
traits, coping styles and social support, when addressing DD.
A number of studies have shown an association be-
tween DD and depression 
67. Diabetes-specific emotional
problems were most common in patients with a comorbid
depressive disorder 
68. DD was shown to be significantly re-
lated to the severity of depressive symptoms, independent of
physical complications and glycemic control 
69. DD, severity
of baseline depression and a degree to which depression dis-
rupted patients' quality of life were shown to be independent
predictors of 1-year depression outcomes 
70. DD was associ-
ated with higher levels of depression and poor emotional
well-being 
71 and
 mediated the relation between depression
and glycemic control 
72, 73. Our recent cross-sectional study 
74
indicated that the level of DD was significantly higher in pa-
tients with a comorbid major depression in comparison to
those without, as well as that DD, extra-disease stressful life
events and polineuropathy were significant predictors of de-
pression.
Incomplete therapeutic adherence, reduced self-
efficacy, negative attitudes toward treatment (introduction of
insulin treatment) are the components of DD that can result
in poor glycemic control. The influence of sociodemographic
factors (gender, education level, socio-economic status, cul-
tural environment) as well as psychological characteristics of
individuals and the presence of symptoms of depression were
significantly associated with DD and glycemic control. Bet-
ter glycemic control can be achieved by appropriate inter-
ventions (person-centred, i.e. adjusted to the personal and
social characteristics of the patients) to overcome DD. It is
obvious that the course and outcome of the illness depend
not only on the application of optimal hypoglycemic therapy,
but also on the timely detection of DD, and the implementa-
tion of interventions aimed at changing attitudes and behav-
ior of patients and alleviating fears associated with the illness
and its treatment.
Recognition of diabetes-related distress
Peyrot et al. 
37 have shown that most health providers of
the countries studied are aware of the level of patient's dis-
tress secondary to diabetes. In spite of this general aware-
ness, many providers had a lack of confidence in their ability
to identify and evaluate psychological problems and to pro-
vide support for their patients. Thus, these factors remain
considerable barriers to managing negative emotions more
effectively and improving quality of life in this population of
patients. Recognition of DD and application of effective
strategies to reduce its intensity, even if diabetes self-care is
adequate might be a key health care intervention in patients
with diabetes.
Discussion about distress may be the most effective
clinical approach and the first step in detection of psycho-
logical problems related to diabetes. Many diabetic patients
hesitate to talk to their physician about emotional distress
and prefer to report medical symptoms and complaints.
Some patients spontaneously express their DD, often in
terms of demoralization about their ability to manage their
diabetes and an unwillingness or inability to engage in active
self-management despite recognition of the need for
change 
75. The next step in identifying patients with DD
would be asking questions about specific sources and inten-
sity of the distress (having trouble accepting diabetes, feeling
overwhelmed or burned out by the demands of diabetes
management, getting support from family and worry about
getting complications).
The ability of depression screening measures to identify
DD is modest 
76. The Problem Areas in Diabetes (PAID)
questionnaire 
39, that takes less than 5 minutes, could be use-
ful. Shorter versions of the PAID, PAID-5 and PAID-1 (only
one question referring to worrying about the future and seri-
ous complications), appear to be psychometrically robust
measures of DD 
77.
Recognition of DD and mental disorders associated
with diabetes is very important for primary care physicians,
who participate in the implementation of prevention and
treatment of DMT2 as well as other chronic somatic dis-
eases 
36. Since detection of patients with severe mental dis-
orders by primary care physicians is better than detection of
subthreshold symptoms, mild form of anxiety and other fac-
tors making distress related to disease 
78, it is necessary to
provide special training for primary care physicians by men-
tal health care specialists, which would significantly advance
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cal guidelines for screening and application of necessary in-
terventions for alleviation of emotional reactions and im-
provement of health behavior and compliance with treatment
would be very useful. Education should be held continu-
ously, in other to provide the newest methods and results in
that field of clinical practice.
The symptoms of several psychiatric conditions such as
adjustment disorder, depression and anxiety disorders could
overlap with emotional and behavioural problems that make
DD. Distinguishing DD from these mental disorders is im-
portant due to necessity to implement appropriate interven-
tions that would be more efficient than treatment specifically
directed at clinical depression and other mental disorders 
79.
Depression is related to, but distinct from, diabetes dis-
tress. There has been considerable confusion among major
depressive disorder (MDD), diabetes distress, and depressive
symptoms. The physical symptoms associated with diabetes
could also complicate distress assessment because they may
be mistaken for symptoms of MDD 
80, 81. It is important to
know that the connection between chronic illness and de-
pressive symptoms diminishes with age, as does the associa-
tion between functional disability and depressive symptoms.
Expectations of functioning in important roles appear crucial
for explaining the link between disease and significant emo-
tional distress.
Interventions to reduce the intensity of
diabetes-related distress
The intensity of DD can vary considerably over time,
depending on diabetes status, and should be regularly evalu-
ated as part of a comprehensive diabetes care. Because of the
bidirectional relationship between distress and diabetes man-
agement, interventions that focus on addressing both DD and
diabetes management are likely to have maximal effects.
Initiating discussion about DD by health provider could
act positively on patients. Even brief conversations that ad-
dress feelings and link them to difficulties with self-
management could normalize emotional reactions related to
disease. The patient's verbalization and expression of emo-
tional experiences of having diabetes can be therapeutic. Be-
cause of the reciprocal influences between emotional distress
and diabetes self management, integrative approach (psy-
chological treatment and changes in health behaviour) that
target both of these problems are likely to have stronger ef-
fects on diabetes health outcome than those that focus on ei-
ther in isolation 
81. It includes participation of nurses, nutri-
tionists, health psychologists and psychiatrists. Taking into
account that patients on insulin therapy represent group with
more severe form of DMT2 requiring more demanding self-
management, interventions leading to both reduction of dis-
tress and better health behaviour would be of particular im-
portance.
A recent randomized study of the new developed pro-
gram for the initiation of intensive insulin therapy in DMT2
patients (MEDIAS 2 ICT: More Diabetes Self-management
for Type 2 Diabetes – Intensive Conventional Insulin Ther-
apy) conducted as group sessions in comparison with an es-
tablished education program (a combination of two older
education programs regarding initiating mealtime insulin and
treating hypertension) as an active comparator condition,
has shown that this program was as effective in lowering
HbA1c as the control education program, but superior in re-
ducing DD. A key element of that program is shared deci-
sion-making between patients and diabetes educators refer-
ring to realistic treatment goals. The patients discuss individ-
ual problems and barriers to achieving the treatment goals
and methods to overcome the barriers as well as attitudes and
personal perceptions about certain aspects of diabetes treat-
ment. An important issue of that program is social support
with an active participation of family members, partners or
friends of patients with diabetes 
82.
Ethnic minorities with low socio-economic status are
the group of patients with risk for unfavourable diabetes out-
come. The treatment adapted to educational level and social
characteristics of the patients appear to be successful. A pilot
study 
83 demonstrated that literacy-adapted, intensive, prob-
lem-solving-based diabetes self-management training was ef-
fective for key clinical and behavioural outcomes in a sample
of patients with lower income.
In a review by Plack et al. 
84 summarizing the effects of
interventions on metabolic control and other medical vari-
ables, as well as diabetes self-management and psychological
outcomes it was concluded that behavioral interventions are
effective in diabetes treatment, especially in patients with a
high level of DD, difficulty in coping, or insufficient blood
glucose awareness.
Novel approaches to the emotional and self-
management problems related to diabetes are clearly needed
for the far larger population of patients struggling with dis-
ease-related distress.
Patients who experience long-standing and profound
diabetes distress and those who have any mental disorder
may require a referral for specialized care. Efficient consul-
tation-liaison services (with psychiatrists and psychologists
who are integrated into the multidisciplinary diabetes care
team)  and education of endocrinologists in recognition of
diabetes distress as well as psychiatric disorders associated
with diabetes would be necessary for the implementation of
integrative treatment of these patients.
To our mind, the main limitations of previous studies
on disease related distress in DMT2 patients would be meth-
odological problems related to the proper diagnosis of
comorbid depression and its differentiation from the disease
related distress. It is therefore necessary to use structured di-
agnostic interviews for mental disorders, because it has been
shown 
38 that a considerable number of DMT2 patients had
high levels of depressive symptoms on self-report measures
and were not clinically depressed when structured interviews
were used. In addition, more prospective studies on the rela-
tionship between personal characteristics, distress and de-
pression, as well as the impact of distress on clinical and
metabolic parameters of the disease would be of special
clinical significance. Taking into account the increasing
number of DMT2 patients, further studies on the impact of
sociodemographic and clinical factors on the effectiveness ofStrana 1142 VOJNOSANITETSKI PREGLED Volumen 70, Broj 12
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different interventions to reduce DD are needed, as well as
the application of new developed programs and integrated,
multidisciplinary care.
Conclusion
Distress related to disease, a non-psychiatric, subclini-
cal emotional distress is present in many patients with
DMT2. Diabetes-specific distress corresponds to a complex
set of repetitive thoughts regarding feeling of being over-
whelmed by diabetes, worries about access to care, concerns
about diet, physical activity, medications, and not receiving
understanding and appropriate support from others. Distress
secondary to diabetes is a significant contributor to unfa-
vourable disease course and outcome due to its relationship
to both poor metabolic control, suboptimal adherence to
treatment and impairment of quality of life. High level of
diabetes distress is related to a negative appraisal of insulin
therapy and patients' reluctance to both initiate and intensify
treatment with insulin (“psychological insulin resistance“).
Personal characteristics of patients with diabetes, such as
coping style and temperament could also contribute to the
intensity of disease distress.
Recognition of distress related to disease and applica-
tion of effective strategies to reduce its intensity is a key
health care intervention in patients with diabetes. Special
training is needed for primary care physicians in mental
health issues in order to acquire necessary knowledge and
skills in identifying diabetes distress and implement inter-
ventions for its alleviation.
Interventions that aim to alleviate psychological prob-
lems in patients with diabetes, even those that may not meet
diagnostic thresholds, have the potential to not only improve
mental health and quality of life of patients, but may also
have important impact on treatment outcome. In order to
achieve maximal efficacy of these interventions, a compre-
hensive approach is necessary, that integrates the treatment
aimed at reducing fears related to the illness, decreasing so-
cial stigma, improving health behavior and compliance with
dietary regimen. The development of efficient consultation-
liaison services and person-centred medicine in general hos-
pitals with providing education about the psychological as-
pects of diabetes would allow an effective collaboration be-
tween endocrinologists and mental health care professionals
which would lead to the improvement of both the patient's
psychological functioning and disease outcome.
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